TickerGuard
Buy Day today: Good (62) Broad market participation · no major macro event

Momentum & Trend

Qullamaggie: Top Gainers 6M

36 Hits · last calculated September 18, 2026 Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Methodology & criteria

Kullamägi's biggest-gainers screen over 6 months — exactly per his original filters: 6-month Absolute Strength rating (AS) > 97, the strongest roughly 3% over the half-year; plus ADR ≥ 3.5% and average dollar volume over the last 50 days > $1.5M. The long-term leaders — where the cleanest continuation bases form. AS = our RS rating (percentile 1–99).

Global filters: market cap of $50B or less (mega caps are cut from every scanner); 10- and 30-day ADR must be ≥ 1% (too little movement gets cut); names after a reverse split (distorted price history) are excluded.

🔔 Watch scanner

Terms in This Scanner Explained

(17)
Absolute Strength (AS)
The strength rating from Qullamaggie's original tool: a percentile from 1 to 99 for price gains over a period (1, 3, or 6 months). On our site it corresponds to the RS Rating over the same period.
ADR (Average Daily Range)
The average daily swing of a stock in percent - measured over 10 or 30 trading days (columns "ADR 10D/30D"). An ADR of 5% means: on a normal day the gap between the intraday low and high runs about 5%. Traders look for movement - that is why stocks with an ADR under 1% are filtered out globally. Scanners that run without the global filters still include them; that is noted below their hit list. Not to be confused with ADR meaning "American Depositary Receipt" (a US certificate for foreign shares) - here ADR always means the daily swing.
AI Classification
Our company-by-company assessment of the AI boom based on SEC filings (the last four quarterly 10-Q reports and two annual 10-K reports): "Sells AI" (AI is a revenue source), "Threatened" (AI is a concrete business risk), "Uses AI" (operational use), or "Neutral" (no material AI exposure). Every classification requires at least two direct quote citations - otherwise the column shows "-". Not a quality judgment or a buy recommendation; the full file is on the stock page, methodology at /stocks/ai-rating-methodology.
Analysis (Full Company Analysis)
If the Analysis column shows "Read," there is an in-depth TickerGuard company analysis for this stock: business model, scanner findings, quarterly results, evidence from SEC filings, plus opportunities and risks. One click opens it directly.
Avg/Yr 3Y (Average Annual Return)
The stock's average annual return over the past 3 years. Shows at a glance whether a stock delivers over the long run or just had a short hot streak.
Earnings Date
The date of the next quarterly earnings report. Price gaps in either direction are common around this date - that is why we color it red when it is 7 days away or less, and yellow when it is 14 days away or less: elevated risk for fresh positions.
EPS (Earnings per Share)
Quarterly earnings divided by the number of shares outstanding. The most important growth metric: if EPS rises strongly over several quarters, the company is earning more money per share.
Free Cash Flow (FCF)
Operating cash flow minus capital expenditures - the money left over for everything else (debt paydown, acquisitions, or buybacks). Consistently positive free cash flow is one of the most honest signs of a healthy business model.
Funda Rating (Fundamental Rating A+ to F)
Our proprietary fundamental rating from 0 to 100 points with a school-grade rank from A+ to F. 50 points is the average across the universe, 100 the best possible score. Every stock is scored against all others by percentile: growth in earnings and revenue, earnings surprises, analyst estimates, and quality criteria such as margins, cash flow, and balance-sheet strength. Grades: A+ from 95, A from 75, B from 55, C from 45, D from 25, E from 5, F below — A/A+ are the fundamentally strongest stocks in the universe.
Long / Short
Long = betting on rising prices (buying the stock). Short = betting on falling prices (selling borrowed shares to buy them back cheaper later). Our short scanners are warning or watch lists - not buy candidates.
Market Capitalization (Mkt Cap)
The market value of the company: share price x total shares outstanding, shown here in billions of dollars. Micro caps (< $0.3B) are small and volatile, mega caps (> $200B) are heavyweights. Our scanner universe is deliberately capped at $50B - we look for stocks with room to run. The cap does not apply to scanners that run without the global filters; that is noted below their hit list.
Net Margin
How much of revenue is left as profit? Net income divided by revenue, in percent. A 20% margin means: out of every dollar of revenue, 20 cents is left as profit. Rising margins are a strong quality signal.
Operating Cash Flow (OCF)
The cash that actually flows into the company from day-to-day operations - without accounting effects such as depreciation. A company can report book profits while still burning cash; operating cash flow reveals that.
Piotroski F-Score
A balance-sheet health check developed by Joseph Piotroski: 9 yes/no criteria covering earnings, cash flow, leverage, and efficiency produce a score from 0 to 9. Scores of 7 or higher are considered financially very solid, scores under 3 a warning sign.
Relative Strength (RS Rating)
How much has a stock risen compared with every other stock? The RS Rating is a percentile from 1 to 99: RS 90 means the stock has outperformed 90% of all stocks (depending on the scanner, over 1 week, 1, 3, 6, or 12 months). Market leaders almost always carry high RS values - that is why relative strength is the core of many momentum strategies.
Sector & Industry
Two levels of industry classification: sector is broad (e.g., Technology), industry is narrow (e.g., Semiconductors). Many strategies watch industry strength, because strong stocks are almost always found in strong industries.
Stage (Weinstein Stages 1-4)
Stan Weinstein divides every price chart into four stages: Stage 1 = basing (sideways after a downtrend), Stage 2 = uptrend (the only buying stage), Stage 3 = topping, Stage 4 = downtrend (avoid, or short candidate). Measured against the 30-week line (150-day moving average) and its slope.

View all terms in the Scanner Glossary

Hit List

Filter

Rating (traffic light)

Stage

Funda Rating

Piotroski

Columns

This scanner's columns

Extra columns

Tip: clicking a column header sorts the table by that column; a second click flips the direction.

Qullamaggie: Top Gainers 6M
Symbol Earnings Avg/Y 3Y Volatility Stage Funda Rating Piotroski MktCap Industry AI Rating Deep Dive Deep-Dive Report Sector Price YTD 6 Mo. 1 Year Off High Price Target RS EPS Rating ADR 10D ADR 30D Beta P/E P/E (f) P/S P/B P/FCF PEG EV/EBITDA EBIT Margin Gross Margin Net Margin ROE ROA Debt/Eq Equity Ratio Sales +/Y Growth Score Div. Yield Payout Ratio Altman Z Inst. % Short % Analysts
VICR Vicor Corporation 07/28 +178 % ⚠ Wildest 10% 94 % Stage 2 A 77 5 of 9 10.7 $ Electronic Components Neutral
Read
— Technology 216.40 $ +206.7 % +238.2 % +314.5 % −10.2 % +78.5 % 99 96 9.3 % 9.4 % 2.36 69.1 32.4 22.7 12.5 122.7 — 73.4 15.0 % 56.6 % 30.7 % 20.5 % 7.5 % 0.01 93.7 % +13.6 % 8 0.0 % 0.0 % 26.2 63.3 % 8.5 % 3.3 (4)
MXL MaxLinear Inc 07/22 +69 % ⚠ Wildest 10% 113 % Stage 2 B 64 4 of 9 6.7 $ Semiconductors Sells AI
Read
— Technology 75.00 $ +411.1 % +518.4 % +364.1 % −11.1 % +26.1 % 99 8 10.9 % 11.9 % 3.95 — 25.1 11.8 13.2 2,037.3 0.39 12.3 -12.2 % 57.5 % -18.2 % -27.9 % -4.9 % 0.33 58.9 % +29.7 % 4 0.0 % 0.0 % 2.4 87.4 % 6.9 % 4.2 (11)
SYRE Spyre Therapeutics Inc. 08/04 +290 % 68 % Stage 2 D 44 2 of 9 8.3 $ Biotechnology – — — Healthcare 92.70 $ +196.2 % +172.8 % +515.8 % −13.1 % +29.5 % 99 1 7.6 % 6.7 % 3.00 — 0.0 — 15.6 — — -8.0 0.0 % — 0.0 % -31.1 % -19.8 % — 87.8 % -100.0 % 2 0.0 % 0.0 % 9.5 93.2 % 14.4 % 4.8 (11)
AEHR Aehr Test Systems 07/14 +52 % ⚠ Wildest 10% 124 % Stage 2 B 56 2 of 9 2.9 $ Semiconductor Equipment & Materials – — — Technology 90.60 $ +407.1 % +329.4 % +219.6 % −22.0 % +41.3 % 99 4 11.7 % 12.5 % 3.07 — 106.4 57.0 19.2 — 0.77 29.8 -41.0 % 35.3 % -14.2 % -8.7 % -4.5 % 0.07 88.4 % -11.0 % 4 0.0 % 0.0 % 13.6 73.3 % 14.0 % 4.0 (2)
ERAS Erasca Inc 08/11 +154 % ⚠ Wildest 10% 108 % Stage 2 D 27 2 of 9 4.9 $ Biotechnology Uses AI
Read
— Healthcare 15.30 $ +305.1 % +433.2 % +818.6 % −38.4 % +57.6 % 99 42 8.6 % 8.3 % 0.65 — 0.0 — 12.0 — — -1.6 0.0 % — 0.0 % -69.9 % -21.4 % 0.12 85.3 % — 3 0.0 % 0.0 % 1.0 93.3 % 9.9 % 4.6 (8)
AXTI AXT Inc 07/30 +758 % ⚠ Wildest 10% 152 % Stage 2 A 79 6 of 9 4.4 $ Semiconductor Equipment & Materials – — — Technology 67.80 $ +376.5 % +376.1 % +1,619.5 % −51.8 % +35.1 % 99 13 14.0 % 14.6 % 1.92 — 24.3 35.4 16.2 — 12.09 228.3 — 32.2 % 3.2 % -5.0 % 0.3 % 0.26 — -11.1 % 4 0.0 % 0.0 % 7.6 58.1 % 14.6 % 4.8 (5)
OPTX Syntec Optics Holdings Inc. — -28 % ⚠ Wildest 10% 139 % Stage 2 D 31 4 of 9 0.3 $ Electronic Components – — — Technology 6.70 $ +289.2 % +326.6 % +279.7 % −34.3 % — 99 13 12.3 % 15.1 % -0.76 — 0.0 9.3 — — — 254.5 — 19.6 % -8.3 % -30.0 % -2.6 % — — -4.6 % 3 0.0 % 0.0 % 5.1 3.5 % 21.4 % —
TTMI TTM Technologies Inc 07/29 +498 % 81 % Stage 2 B 66 6 of 9 11.9 $ Electronic Components – — — Technology 114.80 $ +208.9 % +157.3 % +134.1 % −5.9 % +89.3 % 98 50 7.5 % 8.3 % 2.15 93.8 5.6 3.5 9.8 — 0.36 30.2 8.6 % 21.2 % 7.0 % 11.4 % 5.3 % 0.90 46.2 % +19.0 % 6 0.0 % 0.0 % 7.0 96.0 % 4.4 % 4.8 (4)
DOCN DigitalOcean Holdings Inc 08/04 +102 % 82 % Stage 2 B 70 4 of 9 14.7 $ Software - Infrastructure – — — Technology 133.00 $ +226.6 % +204.8 % +266.8 % −22.5 % +41.5 % 98 11 8.4 % 8.1 % 1.57 56.6 64.9 14.5 15.1 741.5 1.54 39.4 14.2 % 57.2 % 23.3 % 70.0 % 3.9 % 1.68 34.5 % +15.5 % 9 0.0 % 0.0 % 5.1 94.1 % 8.8 % 3.6 (14)
HUT Hut 8 Corp. 08/06 +241 % ⚠ Wildest 10% 107 % Stage 2 B 58 5 of 9 10.0 $ Capital Markets Sells AI
Read
— Financial Services 91.00 $ +162.3 % +124.0 % +140.8 % −16.4 % +77.8 % 98 98 8.9 % 9.3 % 5.98 — 138.9 31.6 7.1 — — 11.6 -521.5 % 62.3 % -188.6 % -27.4 % -9.7 % 0.36 52.9 % -90.7 % 1 0.0 % 0.0 % 3.4 80.5 % 13.2 % 4.6 (15)
AAOI Applied Optoelectronics, Inc. 08/06 +1,099 % ⚠ Wildest 10% 140 % Stage 2 C 53 4 of 9 7.9 $ Communication Equipment Sells AI — — Technology 98.10 $ +322.9 % +266.1 % +232.8 % −40.7 % +66.6 % 98 42 12.0 % 12.7 % 3.78 — 84.0 13.2 7.2 — 0.78 38.4 -8.6 % 28.9 % -9.6 % -6.1 % -2.7 % 0.16 70.6 % +82.8 % 5 0.0 % 0.0 % 7.6 68.3 % 14.8 % 4.2 (5)
VSH Vishay Intertechnology Inc 08/05 +42 % 68 % Stage 2 B 69 7 of 9 4.7 $ Semiconductors Uses AI
Read
— Technology 31.90 $ +309.9 % +277.5 % +113.6 % −13.8 % +24.1 % 98 3 10.5 % 10.5 % 1.81 2,905.8 18.0 1.4 1.9 53.6 1.35 13.5 2.4 % 20.0 % 0.9 % 0.1 % 0.8 % 0.53 48.7 % +4.5 % 3 1.3 % 137.9 % 6.9 109.0 % 12.6 % 3.8 (4)
UCTT Ultra Clean Holdings Inc 07/27 +70 % ⚠ Wildest 10% 88 % Stage 2 C 50 2 of 9 3.3 $ Semiconductor Equipment & Materials Uses AI
Read
— Technology 67.50 $ +340.7 % +399.2 % +160.7 % −3.5 % +103.0 % 98 17 8.9 % 8.7 % 1.88 — 10.5 1.5 4.9 — 0.30 24.9 2.1 % 15.8 % -1.1 % -22.5 % 2.1 % 1.52 33.9 % -2.1 % 5 0.0 % 0.0 % 6.3 102.9 % 10.7 % 4.8 (4)
ORKA Oruka Therapeutics, Inc. 08/10 +78 % 73 % Stage 2 D 37 1 of 9 6.0 $ Biotechnology – — — Healthcare 97.70 $ +175.2 % +188.0 % +502.9 % −4.8 % +58.6 % 98 42 7.5 % 6.8 % -0.21 — 0.0 — 12.5 — — 0.0 0.0 % — 0.0 % -27.3 % -13.0 % 0.00 96.5 % +1,105.3 % 2 0.0 % 0.0 % 34.0 89.1 % 17.1 % 4.9 (8)
PENG Penguin Solutions, Inc. 07/07 +53 % 82 % Stage 2 B 70 7 of 9 2.7 $ Information Technology Services Sells AI
Read
— Technology 52.60 $ +242.3 % +236.2 % +100.0 % −13.7 % +59.4 % 98 50 11.5 % 11.1 % 2.85 94.5 12.5 2.0 8.5 25.6 — 16.3 7.8 % 27.9 % 6.5 % 9.6 % 3.9 % 0.94 34.2 % +16.9 % 4 0.0 % 0.0 % 6.7 117.0 % 18.0 % 4.3 (8)
TNGX Tango Therapeutics Inc 08/04 +91 % ⚠ Wildest 10% 93 % Stage 2 D 36 4 of 9 3.8 $ Biotechnology – — — Healthcare 23.50 $ +220.4 % +274.3 % +208.3 % −12.4 % +84.4 % 98 50 6.5 % 9.4 % 1.12 — 0.0 71.1 — — — -0.9 -206.2 % -148.4 % -229.9 % -38.4 % -13.0 % — 89.8 % +48.3 % 3 0.0 % 0.0 % 11.7 113.9 % 25.6 % 4.8 (8)
ICHR Ichor Holdings Ltd 11/02 +53 % ⚠ Wildest 10% 99 % Stage 2 B 62 4 of 9 1.9 $ Semiconductor Equipment & Materials – — — Technology 53.00 $ +400.3 % +460.1 % +221.3 % −6.5 % +80.9 % 98 28 9.2 % 8.9 % 1.81 — 15.1 1.8 — — 0.22 288.9 1.1 % 12.7 % -4.0 % -7.4 % 0.4 % — 68.7 % +11.6 % 2 0.0 % 0.0 % 7.5 95.3 % 7.8 % 4.4 (7)
VPG Vishay Precision Group Inc 08/04 +90 % 83 % Stage 2 C 48 4 of 9 0.9 $ Scientific & Technical Instruments – — — Technology 62.10 $ +248.5 % +260.0 % +92.0 % −9.7 % +50.3 % 98 3 8.4 % 9.5 % 1.42 — 35.1 2.6 — — 1.75 30.8 0.9 % 38.8 % 1.2 % 1.8 % 1.1 % — 73.8 % +0.2 % 3 0.0 % 0.0 % 10.5 98.4 % 11.4 % 5.0 (2)
BAND Bandwidth Inc 10/29 +106 % ⚠ Wildest 10% 90 % Stage 2 C 51 7 of 9 1.6 $ Software - Infrastructure Sells AI
Read
— Technology 50.50 $ +241.3 % +304.3 % +176.2 % −31.1 % +40.1 % 98 42 8.6 % 8.7 % 3.03 — 23.0 2.1 3.6 21.1 — 32.6 -2.2 % 37.2 % 0.3 % -1.4 % -0.9 % 1.04 41.2 % +0.7 % 3 0.0 % 0.0 % 3.6 80.1 % 14.7 % 3.3 (6)
HYLN Hyliion Holdings Corp. 08/11 +90 % ⚠ Wildest 10% 99 % Stage 2 C 54 4 of 9 0.7 $ Auto Parts Uses AI
Read
— Consumer Cyclical 4.10 $ +231.5 % +141.9 % +130.5 % −42.8 % +110.5 % 98 50 13.6 % 15.8 % 3.54 — 0.0 79.7 — — — -0.8 -481.7 % 6.5 % 0.0 % -25.2 % -18.3 % — 95.3 % +130.3 % 6 0.0 % 0.0 % 21.4 25.2 % 12.6 % 3.0 (1)
SLS Sellas Life Sciences Group Inc 08/11 +148 % ⚠ Wildest 10% 104 % Stage 2 B 58 3 of 9 2.3 $ Biotechnology Uses AI
Read
— Healthcare 11.50 $ +140.6 % +444.0 % +582.3 % −4.8 % +177.8 % 98 50 12.4 % 11.1 % 2.53 — 0.0 — — — — -1.7 0.0 % — 0.0 % -43.6 % -23.3 % — 94.1 % -100.0 % 1 0.0 % 0.0 % 16.0 27.6 % 28.8 % 4.7 (3)
ALOT AstroNova Inc — +30 % 68 % Stage 2 C 51 9 of 9 0.2 $ Computer Hardware Neutral
Read
— Technology 29.00 $ +228.3 % +249.6 % +178.5 % −0.8 % -10.3 % 98 81 8.8 % 6.2 % 0.86 — 14.0 1.5 — 22.6 — 39.5 — 33.8 % -0.9 % -1.8 % 2.6 % — — -0.5 % 3 0.0 % 0.0 % 7.3 44.9 % 0.5 % —
STRL Sterling Construction Company Inc 11/02 +532 % 86 % Stage 2 A 84 7 of 9 16.2 $ Engineering & Construction Uses AI — — Industrials 505.70 $ +191.4 % +159.2 % +51.1 % −12.3 % +81.5 % 97 88 7.1 % 7.5 % 1.85 41.9 18.0 4.7 12.1 33.8 0.58 20.2 17.2 % 23.8 % 12.6 % 36.7 % 14.5 % 0.57 42.7 % +17.7 % 5 0.0 % 0.0 % 6.7 95.7 % 4.6 % 5.0 (3)
NVTS Navitas Semiconductor Corp 08/03 -3 % ⚠ Wildest 10% 123 % Stage 2 D 32 2 of 9 2.8 $ Semiconductors – — — Technology 11.10 $ +199.7 % +131.6 % +72.5 % −48.2 % +26.8 % 97 42 10.1 % 12.8 % 3.88 — 0.0 75.6 6.8 — — -7.7 -317.7 % 38.1 % 0.0 % -35.2 % -9.0 % 0.02 87.3 % -44.9 % 3 0.0 % 0.0 % 7.5 46.3 % 17.2 % 4.0 (8)
ATEX Anterix Inc 08/11 +51 % 61 % Stage 2 B 66 7 of 9 1.5 $ Telecom Services Neutral
Read
— Communication Services 77.40 $ +266.4 % +339.9 % +263.0 % −8.1 % +45.1 % 97 85 8.3 % 8.2 % 0.84 17.7 0.0 203.2 6.3 100.2 — -12.4 — 100.0 % 933.0 % 43.3 % -5.9 % 0.02 — +7.8 % 6 0.0 % 0.0 % 3.5 91.8 % 13.3 % 4.7 (3)
QUIK QuickLogic Corporation 08/11 +46 % 83 % Stage 2 C 49 7 of 9 0.2 $ Semiconductors – — — Technology 10.50 $ +231.7 % +196.4 % +90.2 % −24.3 % +130.0 % 97 42 8.5 % 9.5 % 1.20 — 114.9 11.5 — — 5.30 20.7 — 27.3 % -80.1 % -49.2 % -15.1 % — — -31.5 % 3 0.0 % 0.0 % -28.1 28.3 % 9.4 % 5.0 (2)
RFIL RF Industries Ltd — +133 % ⚠ Wildest 10% 89 % Stage 2 B 72 7 of 9 0.1 $ Electrical Equipment & Parts Neutral
Read
— Industrials 7.90 $ +265.4 % +254.2 % +12.0 % −6.1 % +107.3 % 97 61 12.2 % 9.9 % 1.30 60.5 9.9 1.0 2.3 27.5 — 18.3 — 35.1 % 2.8 % 3.9 % 4.3 % 0.65 — +24.3 % 5 0.0 % 0.0 % 6.5 44.1 % 7.8 % 5.0 (1)
CVGI Commercial Vehicle Group Inc 08/03 -17 % 83 % Stage 2 C 46 7 of 9 0.1 $ Auto Parts – — — Consumer Cyclical 3.00 $ +228.5 % +212.2 % +58.0 % −19.4 % +141.9 % 96 70 7.6 % 7.1 % 1.38 — 31.4 0.1 0.8 — 1.26 13.7 — 12.0 % -3.4 % -12.3 % 0.6 % 0.78 — -10.3 % 4 0.0 % 0.0 % 5.4 46.7 % 4.2 % 4.5 (2)
MGNX MacroGenics Inc 08/13 -6 % 80 % Stage 2 C 53 5 of 9 0.3 $ Biotechnology – — — Healthcare 4.10 $ +191.3 % +200.0 % +169.9 % −8.3 % +95.1 % 96 8 8.1 % 7.0 % 1.23 — 61.0 1.6 — — 0.01 -1.5 — -0.7 % -8.3 % -140.3 % -8.1 % — — +0.8 % 3 0.0 % 0.0 % -15.0 70.3 % 11.6 % 3.7 (7)
STRO Sutro Biopharma 08/06 -14 % ⚠ Wildest 10% 89 % Stage 2 D 30 6 of 9 0.3 $ Biotechnology – — — Healthcare 15.50 $ +152.3 % +210.2 % +81.5 % −32.6 % +184.5 % 96 42 9.7 % 10.4 % 1.49 — 10.0 5.6 1.1 — — 41.7 — -216.7 % 0.0 % -1,810.0 % -36.1 % -0.20 — +65.2 % 2 0.0 % 0.0 % -9.7 86.8 % 11.0 % 3.7 (10)
SVCO Silvaco Group, Inc. 08/05 — ⚠ Wildest 10% 88 % Stage 2 C 53 4 of 9 0.2 $ Software - Application Sells AI — — Technology 6.70 $ +218.0 % +185.7 % +19.2 % −15.5 % +133.3 % 96 42 9.8 % 9.6 % 0.58 — 22.4 3.1 2.7 — — 194.4 — 83.2 % -30.4 % -34.7 % -9.6 % 0.03 — +5.7 % 4 0.0 % 0.0 % 2.2 24.3 % 11.7 % 4.8 (6)
ELVN Enliven Therapeutics Inc. 08/12 +44 % 74 % Stage 2 D 32 4 of 9 3.4 $ Biotechnology – — — Healthcare 50.20 $ +215.6 % +203.9 % +164.1 % −2.8 % +47.2 % 95 42 6.6 % 6.9 % 0.25 — 0.0 — 8.1 — — -6.3 0.0 % — 0.0 % -26.6 % -11.0 % 0.00 97.5 % — 2 0.0 % 0.0 % 47.0 89.7 % 16.9 % 4.9 (8)
IBRX Immunitybio Inc 08/04 +57 % ⚠ Wildest 10% 99 % Stage 2 C 49 3 of 9 8.8 $ Biotechnology Uses AI
Read
— Healthcare 8.50 $ +269.7 % +309.8 % +206.5 % −37.3 % +50.0 % 94 42 7.8 % 7.0 % 0.14 — 116.3 53.0 — — — -9.0 -157.9 % 99.3 % 0.0 % 0.0 % -30.5 % — -134.5 % +668.3 % 6 0.0 % 0.0 % -23.1 17.6 % 31.3 % 4.6 (5)
ATOM Atomera Inc 08/04 +0 % ⚠ Wildest 10% 136 % Stage 2 C 50 7 of 9 0.2 $ Semiconductor Equipment & Materials – — — Technology 4.00 $ +240.7 % +238.2 % +17.4 % −40.9 % +156.4 % 94 42 9.6 % 11.6 % 2.03 — 0.0 516.7 3.8 — — -8.7 — -78.7 % 0.0 % -65.9 % -45.7 % 0.03 — -51.9 % 3 0.0 % 0.0 % 1.4 42.1 % 17.3 % 5.0 (1)
SATL Satellogic V Inc 08/11 +64 % ⚠ Wildest 10% 127 % Stage 2 B 55 5 of 9 0.8 $ Aerospace & Defense – — — Industrials 5.50 $ +197.3 % +157.5 % +56.1 % −61.8 % +85.5 % 89 42 10.6 % 11.7 % 1.36 — 500.0 26.2 23.8 — — 245.5 — 78.9 % 0.0 % -127.6 % -9.9 % -5.86 — +37.6 % 4 0.0 % 0.0 % -6.2 55.4 % 15.3 % —
HURA TuHURA Biosciences Inc 08/13 -33 % ⚠ Wildest 10% 124 % Stage 3 D 31 3 of 9 0.1 $ Biotechnology Neutral
Read
— Healthcare 2.10 $ +248.7 % +177.9 % -14.0 % −33.6 % +302.0 % 86 42 10.2 % 9.0 % — — 0.0 — — — — 0.0 — — 0.0 % -187.2 % -58.4 % — — — 2 0.0 % 0.0 % -16.0 15.0 % 12.7 % 4.0 (2)

Price Chart

Quarterly Figures

No quarterly data available.

Frequently Asked Questions

Kullamägi's biggest-gainers screen over 6 months — exactly per his original filters: 6-month Absolute Strength rating (AS) > 97, the strongest roughly 3% over the half-year; plus ADR ≥ 3.5% and average dollar volume over the last 50 days > $1.5M. The long-term leaders — where the cleanest continuation bases form. AS = our RS rating (percentile 1–99).

All scanners are recalculated daily across the entire stock universe — most recently on September 18, 2026. The data basis is fundamental data and SEC filings (10-K annual reports and 10-Q quarterly reports).

Currently, 36 stocks pass this scanner's criteria (as of September 18, 2026).

Global filters: market cap of $50B or less (mega caps are cut from every scanner); 10- and 30-day ADR must be ≥ 1% (too little movement gets cut); names after a reverse split (distorted price history) are excluded.

Related scanners

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?